SAEED SHAH: Open Payments
NPI 1700831344 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,191 in 52 payments from 7 companies in 2025. Trend: 2023 $745 · 2024 $16,439 · 2025 $13,191
Consulting: $6,500Speaker / faculty: $4,580Travel & lodging: $1,244Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 26 | $12,702 |
| Janssen Pharmaceuticals, Inc | 11 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: LYBALVI, INVEGA SUSTENNA, CAPLYTA, INGREZZA, ARISTADA, ABILIFY MAINTENA, COBENFY, REXULTI.
Industry payments across AL — which companies pay providers there.
